Gene: GARIN2
Official Full Name: golgi associated RAB2 interactor family member 2provided by HGNC
Gene Summary: Predicted to be involved in flagellated sperm motility. Predicted to act upstream of or within cell morphogenesis and vacuole organization. Predicted to be located in sperm midpiece. Predicted to be active in sperm head. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17455 | GARIN2 Knockout cell line (HeLa) | Human | GARIN2 | 1:3~1:6 | Negative | Online Inquiry |
KO17456 | GARIN2 Knockout cell line (HCT 116) | Human | GARIN2 | 1:2~1:4 | Negative | Online Inquiry |
KO17457 | GARIN2 Knockout cell line (HEK293) | Human | GARIN2 | 1:3~1:6 | Negative | Online Inquiry |
KO17458 | GARIN2 Knockout cell line (A549) | Human | GARIN2 | 1:3~1:4 | Negative | Online Inquiry |
GARIN2 Gene Knockout Cell Lines are advanced cellular models specifically designed to study the function and implications of the GARIN2 gene through targeted gene deletion. These cell lines are engineered using precise CRISPR/Cas9 gene editing technology, facilitating the production of knockout variants that eliminate the expression of the GARIN2 gene. This allows researchers to investigate the gene's role in various biological processes, including cell growth, differentiation, and response to external stimuli.
The key function of GARIN2 knockout cell lines is their ability to support functional assays that elucidate the molecular pathways influenced by GARIN2. By analyzing the phenotypic and genotypic characteristics of these modified cells, scientists can uncover the gene's involvement in disease mechanisms such as cancer progression, neurodegenerative disorders, and immune responses. This rigorous exploration provides valuable insights into therapeutic targets and potential interventions.
From a scientific perspective, GARIN2 knockout cell lines have significant applications in both research and clinical settings. They enable researchers to conduct high-throughput screening, investigate gene-gene interactions, and validate drug candidates. Furthermore, these cell lines are instrumental in providing preclinical data that can guide clinical trial design and patient stratification, enhancing personalized medicine approaches.
What sets GARIN2 knockout cell lines apart from conventional cell models is their specificity and precision. Unlike standard cellular assays, which may yield ambiguous results due to background gene expression, our knockout lines provide a clean slate to study the direct effects of GARIN2 exclusion. This high specificity not only reduces variability in experimental outcomes but also increases the reliability of data, contributing to more robust conclusions.
Researchers, clinicians, and pharmaceutical scientists will find GARIN2 knockout cell lines indispensable for their work, as these models pave the way for significant breakthroughs in understanding gene function and disease pathology. They represent an essential tool that enhances the capability to translate basic research findings into clinical applications.
Our company is dedicated to providing high-quality research tools with a focus on advancing genomic technologies. With expertise in gene editing and a commitment to supporting the scientific community, we are proud to offer GARIN2 knockout cell lines as a vital resource for innovative research initiatives.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.